The figure is slightly lower than the $19.50 per shot the United States agreed to pay for its first shipment of 100 million doses of the same vaccine.
At least 74 million people have been infected by the coronavirus that has claimed more than 1.6 million lives around the world. Here are updates for December 17:
The two companies said they planned to launch another study next year, hoping to come up with a more effective vaccine by the end of 2021.
As the UK rolls out its first Covid-19 jabs, here’s a look at some questions you might have post-immunisation:
As Covid-19 vaccines start to get approval across the world, the task to airlift the much-needed doses is starting to pick up pace, giving airlines a badly needed boost.
Be it government-sanctioned purchases or the private market, the poorest countries will be the last to get rid of the pandemic.
The first doses will be administrated to people over the age of 80, frontline healthcare workers and care home staff and residents.
In a joint statement, both companies say that a completed analysis of their vaccine found it protected 95 percent of people against the disease.
While a Covid-19 vaccine might be in sight, a shortage of cold storage facilities makes delivering it to the poorest people difficult.
Russia's results are only the second from a late-stage human trial, following on swiftly from data released by Pfizer Inc and BioNTech, which said their shot was also more than 90 percent effective.
Produced by Pfizer and BioNTech SE, the vaccine has surpassed other flu vaccines in terms of effectiveness. We explain how.
Pfizer and its German partner BioNTech say their experimental vaccine was more than 90 percent effective in preventing Covid-19. Behind the vaccine, however, is an understated "dream team" of children of Turkish-Germans.
Subscribe to our Youtube channel for all latest in-depth, on the ground reporting from around the world.
Copyright © 2021 TRT World.